Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Clinical trial NCT04556071 · UNKNOWN

Trial details

NCT number: NCT04556071
Sponsor: Xiaoxiang Chen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Fallopian Tube Neoplasms Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Carcinoma, Ovarian Epithelial Ovarian Diseases Adnexal Diseases

Start date: 2020-11-06
Primary completion: 2022-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.